Search
#TomorrowsDiscoveries: Treating Prostate Cancer – Urologic Oncologist Kenneth Pienta
Urologic oncologist Kenneth Pienta and his team are working to identify what keeps disseminated tumor cells asleep or reactivates them so that they can better treat prostate cancer.Fusion Biopsy for Prostate Cancer
Dr. H. Ballentine Carter, professor of urology and oncology, explains the difference between a standard biopsy procedure and a fusion biopsy procedure for prostate cancer.Dawning of a New Era in the Screening and Management of Prostate Cancer
Scott Eggener, MD, discusses the dawning of a new era in the screening and management of Prostate Cancer.Mayo Clinic expert says heart disease from unnecessarily treating "Low T" serious concern
Low T — health risks of testosterone therapy —- Mayo Clinic. William F. Young Jr., M.D.#TomorrowsDiscoveries: Detecting Prostate Cancer Early – Alan Partin, M.D., Ph.D.
Alan Partin, M.D., Ph.D., and his research group develop and test blood, urine and tissue cells to detect prostate cancer early.Optimizing Prenatal Diagnosis of Abdominal Wall Defects — Classic Bladder Exstrophy and Its Imitators
Johns Hopkins pediatric urologist Chad Crigger discusses the latest findings regarding classic bladder exstrophy research, which were presented during the American Pediatric Surgical Association and American Urological Association 2024 annual meetings.Kidney Cancer Q&A
Urologic oncologist Nirmish Singla, M.D., M.S.C.S., discusses our unique approach to treating patients with kidney cancer, including our latest research and clinical trials.Urologist Bladder Cancer Q&A | Max Kates, M.D.
Max Kates, M.D., answers common questions about bladder cancer, including who is at risk, signs and symptoms, as well as the latest treatment options at the Johns Hopkins Greenberg Bladder Cancer Institute.Less-radical procedures offer similar cancer control compared with surgery for kidney cancer patients
Needle-guided tumor destruction procedures offer near-equivalent lengths of local cancer control compared with surgery for patients with small kidney cancer tumors, according to the results of a large study published in the journal European Urology.Urology Speaks: Ecology Meets Cancer Biology: Defining the Keystone Cancer Cell Species to Develop a Cure
Dr. Amend presents background information on the Keystone Cancer Cell, and reviews our current efforts to design treatment strategies that target the unique vulnerabilities of these cells, a theory called evolutionary double bind.Ethical Issues in Live Donor Kidney Transplantation: Illustrative Case-Vignettes
Dr. K.K. Venkat, transplant nephrologist, presents case studies involving ethical decision making.Treatment options for advanced kidney cancer
Bradley C. Leibovich, M.D., a urologic surgeon specializing in the treatment of kidney cancer at Mayo Clinic in Rochester, Minnesota, discusses the symptoms that patients with kidney tumors may — or may not — experience, as well as treatment options available once a tumor is detected.